• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RADBIOMOD:一个用于在放射治疗计划评估中利用生物建模的简单程序。

RADBIOMOD: A simple program for utilising biological modelling in radiotherapy plan evaluation.

作者信息

Chang Joe H, Gehrke Christopher, Prabhakar Ramachandran, Gill Suki, Wada Morikatsu, Lim Joon Daryl, Khoo Vincent

机构信息

Radiation Oncology Centre, Austin Health, Heidelberg, Victoria, Australia; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; University of Melbourne, Victoria, Australia.

Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

出版信息

Phys Med. 2016 Jan;32(1):248-54. doi: 10.1016/j.ejmp.2015.10.091. Epub 2015 Nov 6.

DOI:10.1016/j.ejmp.2015.10.091
PMID:26549777
Abstract

PURPOSE

Radiotherapy plan evaluation is currently performed by assessing physical parameters, which has many limitations. Biological modelling can potentially allow plan evaluation that is more reflective of clinical outcomes, however further research is required into this field before it can be used clinically.

METHODS

A simple program, RADBIOMOD, has been developed using Visual Basic for Applications (VBA) for Microsoft Excel that incorporates multiple different biological models for radiotherapy plan evaluation, including modified Poisson tumour control probability (TCP), modified Zaider-Minerbo TCP, Lyman-Kutcher-Burman normal tissue complication probability (NTCP), equivalent uniform dose (EUD), EUD-based TCP, EUD-based NTCP, and uncomplicated tumour control probability (UTCP). RADBIOMOD was compared to existing biological modelling calculators for 15 sample cases.

RESULTS

Comparing RADBIOMOD to the existing biological modelling calculators, all models tested had mean absolute errors and root mean square errors less than 1%.

CONCLUSIONS

RADBIOMOD produces results that are non-significantly different from existing biological modelling calculators for the models tested. It is hoped that this freely available, user-friendly program will aid future research into biological modelling.

摘要

目的

目前放疗计划评估是通过评估物理参数来进行的,这存在许多局限性。生物建模有可能实现更能反映临床结果的计划评估,然而在其能够用于临床之前,该领域还需要进一步研究。

方法

使用针对Microsoft Excel的应用程序可视化Basic(VBA)开发了一个简单程序RADBIOMOD,该程序纳入了多种不同的用于放疗计划评估的生物模型,包括修正的泊松肿瘤控制概率(TCP)、修正的扎伊德 - 米内尔博TCP、莱曼 - 库彻 - 伯曼正常组织并发症概率(NTCP)、等效均匀剂量(EUD)、基于EUD的TCP、基于EUD的NTCP以及无并发症肿瘤控制概率(UTCP)。将RADBIOMOD与现有的生物建模计算器针对15个样本病例进行了比较。

结果

将RADBIOMOD与现有的生物建模计算器进行比较,所有测试模型的平均绝对误差和均方根误差均小于1%。

结论

对于所测试的模型,RADBIOMOD产生的结果与现有的生物建模计算器相比无显著差异。希望这个免费提供、用户友好的程序将有助于未来生物建模的研究。

相似文献

1
RADBIOMOD: A simple program for utilising biological modelling in radiotherapy plan evaluation.RADBIOMOD:一个用于在放射治疗计划评估中利用生物建模的简单程序。
Phys Med. 2016 Jan;32(1):248-54. doi: 10.1016/j.ejmp.2015.10.091. Epub 2015 Nov 6.
2
"SABER": A new software tool for radiotherapy treatment plan evaluation.“SABER”:一种用于放疗计划评估的新软件工具。
Med Phys. 2010 Nov;37(11):5586-92. doi: 10.1118/1.3497152.
3
Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).从肿瘤控制概率(TCP)和正常组织并发症概率(NTCP)角度看,前列腺癌切缘缩小及治疗技术的放射生物学影响。
Med Dosim. 2011 Summer;36(2):130-7. doi: 10.1016/j.meddos.2010.02.004. Epub 2010 May 21.
4
Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.基于放射生物学指标的螺旋断层放射治疗与基于多叶准直器的调强放射治疗的治疗计划比较
Phys Med Biol. 2007 Jul 7;52(13):3817-36. doi: 10.1088/0031-9155/52/13/011. Epub 2007 May 31.
5
A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD).一种作为等效均匀剂量(EUD)函数的正常组织并发症概率(NTCP)新公式。
Phys Med Biol. 2008 Jan 7;53(1):23-36. doi: 10.1088/0031-9155/53/1/002. Epub 2007 Dec 13.
6
SORS: a new software for the simulation of radiotherapy schedule.SORS:一种用于放疗计划模拟的新软件。
Med Dosim. 2010 Autumn;35(3):208-13. doi: 10.1016/j.meddos.2009.06.005. Epub 2009 Aug 5.
7
Development and validation of an indigenous, radiobiological model-based tumor control probability and normal tissue complication probability estimation software for routine plan evaluation in clinics.开发并验证一种基于本土放射生物学模型的肿瘤控制概率和正常组织并发症概率估算软件,用于临床常规计划评估。
J Cancer Res Ther. 2022 Oct-Dec;18(6):1697-1705. doi: 10.4103/jcrt.JCRT_330_20.
8
Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.剂量计算算法对生物优化的IMRT肺部立体定向体部放射治疗计划的放射生物学影响。
Radiat Oncol. 2016 Jan 22;11:10. doi: 10.1186/s13014-015-0578-2.
9
Direct use of multivariable normal tissue complication probability models in treatment plan optimisation for individualised head and neck cancer radiotherapy produces clinically acceptable treatment plans.在个体化头颈部癌放射治疗的治疗计划优化中直接使用多变量正常组织并发症概率模型可产生临床可接受的治疗计划。
Radiother Oncol. 2014 Sep;112(3):430-6. doi: 10.1016/j.radonc.2014.08.020. Epub 2014 Sep 11.
10
Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complication probability (NTCP).评估和量化鼻咽癌患者的摆位误差及其在广义等效均匀剂量(gEUD)、肿瘤控制概率(TCP)和正常组织并发症概率(NTCP)方面的生物学和剂量学影响。
Br J Radiol. 2015 Jun;88(1050):20140839. doi: 10.1259/bjr.20140839. Epub 2015 Apr 17.

引用本文的文献

1
Dosimetric and Radiobiological Impact of Patient Setup Errors in Intensity-modulated Radiotherapy for Esophageal Cancer.食管癌调强放射治疗中患者摆位误差的剂量学和放射生物学影响
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338241311136. doi: 10.1177/15330338241311136.
2
Artificial neural network-assisted prediction of radiobiological indices in head and neck cancer.人工神经网络辅助预测头颈部癌的放射生物学指标
Front Artif Intell. 2024 Apr 5;7:1329737. doi: 10.3389/frai.2024.1329737. eCollection 2024.
3
And Yet It Moves: Clinical Outcomes and Motion Management in Stereotactic Body Radiation Therapy (SBRT) of Centrally Located Non-Small Cell Lung Cancer (NSCLC): Shedding Light on the Internal Organ at Risk Volume (IRV) Concept.
然而它在移动:中央型非小细胞肺癌(NSCLC)立体定向体部放射治疗(SBRT)中的临床结果与运动管理:揭示危及器官体积(IRV)概念
Cancers (Basel). 2024 Jan 4;16(1):231. doi: 10.3390/cancers16010231.
4
Predicting Overall Survival for Patients with Malignant Mesothelioma Following Radiotherapy via Interpretable Machine Learning.通过可解释机器学习预测恶性间皮瘤患者放疗后的总生存期
Cancers (Basel). 2023 Aug 1;15(15):3916. doi: 10.3390/cancers15153916.
5
Evaluation of Dose-Painting in the Dominant Intraprostatic Lesions by Radiobiological Parameters using Ga- PSMA PET/CT.利用镓-PSMA PET/CT的放射生物学参数评估前列腺主要病灶中的剂量描绘。
J Biomed Phys Eng. 2022 Aug 1;12(4):369-376. doi: 10.31661/jbpe.v0i0.1912-1006. eCollection 2022 Aug.
6
Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial.前列腺癌患者直肠周围水凝胶间隔器插入后接受 82Gy 剂量递增放疗:一项 II 期试验的 3 年结果。
Radiat Oncol. 2022 Jul 25;17(1):131. doi: 10.1186/s13014-022-02103-5.
7
Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers.在前列腺癌极超分割放疗中,针对优势前列腺内病灶同步整合增敏(SIB):直肠间隔物的影响。
Radiat Oncol. 2022 Feb 22;17(1):38. doi: 10.1186/s13014-022-02003-8.
8
Benefits of intraoral stents for sparing normal tissue in radiotherapy of nasopharyngeal carcinoma: a radiobiological model-based quantitative analysis.口腔内支架在鼻咽癌放疗中对保护正常组织的益处:基于放射生物学模型的定量分析
Transl Cancer Res. 2021 Oct;10(10):4281-4289. doi: 10.21037/tcr-21-1324.
9
The Ever-Changing Role of Medical Physicists in the Era of Personalized Medicine.医学物理学家在个性化医疗时代不断变化的角色。
J Med Phys. 2020 Oct-Dec;45(4):197-198. doi: 10.4103/jmp.JMP_113_20. Epub 2021 Feb 2.
10
Comparison of a Hybrid IMRT/VMAT technique with non-coplanar VMAT and non-coplanar IMRT for unresectable olfactory neuroblastoma using the RayStation treatment planning system-EUD, NTCP and planning study.使用 RayStation 治疗计划系统比较不可切除嗅神经母细胞瘤的混合调强放疗/VMAT 技术与非共面 VMAT 和非共面调强放疗-EUD、NTCP 和计划研究。
J Radiat Res. 2021 May 12;62(3):540-548. doi: 10.1093/jrr/rrab010.